Open Now: The Global ETF Survey Take the Survey →
State Street SPDR S&P Biotech ETF
XBI performance and flow charts
Performance
Flows
Historic performance and flows
Data as of July 22, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +4.20% | +10.82% | +24.76% | +76.10% | +83.33% | +19.73% |
| Flows | +$459M | +$279M | +$510M | +$1.45B | -$425M | +$1.59B |
Characteristics
The State Street SPDR S&P Biotech ETF is built to track the S&P Biotechnology Select Industry Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | State Street Investment Management |
| N° of holdings | 153 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | January 31, 2006 |
| ESG | No |
More data and info about XBI on Trackinsight
Exposure
Data as of June 30, 2026Diversification
Total weight of top 15 holdings out of 153
Top 15 Holdings
Sectors
Countries
Latest news about XBI
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +30.98% | +26.78% | +27.91% | +32.90% |
Max drawdown | -8.13% | -9.66% | -32.94% | -54.07% |
Max drawdown duration | 13d | 76d | 331d | 1685d |
Time to recover | N/A | 10d | 183d | 1435d |
Replication quality
Data as of June 30, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is XBI?
XBI is a Passive ETF that provides exposure to Equity assets. It is managed by State Street Investment Management.
What index does XBI track?
XBI tracks the S&P Biotechnology Select Industry Total Return Index - USD, aiming to replicate its performance through full replication.
What does XBI invest in?
This ETF provides exposure to Equally Weighted US Biotechnology Equities. It is part of the segment: US Health Care.
What is the expense ratio of XBI?
The total expense ratio (TER) of XBI is 0.35%, representing the annual fee charged by the fund manager.
When was XBI launched?
XBI was launched on January 31, 2006, marking its entry into the ETF market.
Who is the issuer of XBI?
XBI is issued by State Street Investment Management.
What is the AUM of XBI?
As of July 22, 2026, XBI manages $10.24 B, reflecting the total assets held in the fund.
How has XBI performed recently?
As of July 22, 2026, XBI delivered a return of 4.2% over the past month (1M performance), 10.82% over the past three months (3M), and 24.76% year-to-date (YTD).
What are the recent fund flows for XBI?
As of July 22, 2026, XBI has seen net flows of +$459M in the past month (1M flow) and +$510M year-to-date (YTD).
Does XBI pay dividends?
As of July 22, 2026, XBI has a trailing 12-month distribution yield of 0.38%.
How many holdings are in XBI
As of June 30, 2026, XBI holds 153 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is XBI?
As of June 30, 2026, XBI holds 153 securities, with 19.19% of its assets concentrated in its top 15 holdings.
What are the top holdings of XBI?
As of June 30, 2026, XBI holds a portfolio of 153 underlyings, with its largest positions including Apogee Therapeutics, Inc., Moderna, Inc. and Twist Bioscience Corp.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does XBI invest in?
As of June 30, 2026, XBI has its largest geographic exposures in USA.
What sectors or themes does XBI focus on?
As of June 30, 2026, XBI is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs July 20, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs July 13, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
First Look ETF
First Look ETF: Cash Deployment, Bond, and Hedged ETFs
In this season 6 episode of First Look ETF, Stephanie Stanton examines the latest ETF marketplace trends with NYSE and guests.
ETF Trends
ETF Industry KPIs July 6, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.